Cargando…

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?

Detalles Bibliográficos
Autores principales:	Hassane, Maya, Paget, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919500/ https://www.ncbi.nlm.nih.gov/pubmed/27428409 http://dx.doi.org/10.1016/j.ebiom.2016.05.042

Ejemplares similares

The Yin and Yang of ADCC-Mediating Antibodies
por: Robert-Guroff, Marjorie
Publicado: (2016)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
por: Decaup, Emilie, et al.
Publicado: (2019)

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
por: Eitler, Jiri, et al.
Publicado: (2021)

Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
Publicado: (2021)

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies
por: Miljkovic, Milos D., et al.
Publicado: (2022)

FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV
por: Talathi, Sneha Pramod, et al.
Publicado: (2019)

Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition
por: Di Modica, Martina, et al.
Publicado: (2015)

Augmenting Vaccine Efficacy against Delta Variant with ‘Mycobacterium-w’-Mediated Modulation of NK-ADCC and TLR-MYD88 Pathways
por: Jaiswal, Sarita Rani, et al.
Publicado: (2023)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma
por: Lejeune, Margaux, et al.
Publicado: (2021)

COVID-19 and flu: conserved or specific immune signature?
por: Paget, Christophe, et al.
Publicado: (2021)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program
por: Van Buynder, Paul Gaston, et al.
Publicado: (2021)

Correction: COVID-19 and flu: conserved or specific immune signature?
por: Paget, Christophe, et al.
Publicado: (2022)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
por: Parsons, Matthew S., et al.
Publicado: (2015)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
por: Tang, Jennifer J.-J., et al.
Publicado: (2020)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

ADCC-Mediated CD56(DIM) NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection
por: Yu, Wen-Han, et al.
Publicado: (2018)

Chemotherapy tips the scale in favour of cancer‐fighting B cells
por: Rui, Ke, et al.
Publicado: (2023)

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes
por: Pollara, J, et al.
Publicado: (2012)

COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines
por: Islam, Nazrul, et al.
Publicado: (2020)

Cetuximab intensifies the ADCC activity of adoptive NK cells in a nude mouse colorectal cancer xenograft model
por: Chen, Shanshan, et al.
Publicado: (2016)

Flu Universal Vaccines: New Tricks on an Old Virus
por: Du, Ruikun, et al.
Publicado: (2020)

Universal flu vaccines: a shot at lifelong cardioprotection?
por: Behrouzi, Bahar, et al.
Publicado: (2022)

Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021)

Does Obesity-Induced τ Phosphorylation Tip the Scale Toward Dementia?
por: Gendron, Tania F., et al.
Publicado: (2013)

Deficient IL-2 Produced by Activated CD56(+) T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection
por: Xie, Zhe, et al.
Publicado: (2019)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
por: Mielke, Dieter, et al.
Publicado: (2021)

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
por: Li, Feifei, et al.
Publicado: (2022)

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis
por: Macagno, Marco, et al.
Publicado: (2022)

Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker
por: Schmohl, Joerg U., et al.
Publicado: (2016)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
por: Hagemann, Kerri, et al.
Publicado: (2022)

108 Development of universal vaccines against flu: reality and prospects
por: Shmarov, M.M.
Publicado: (2014)

Factors influencing flu vaccination in nursing students at Palermo University
por: SANTANGELO, OMAR ENZO, et al.
Publicado: (2021)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
por: Deviatkin, Andrei A., et al.
Publicado: (2022)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
por: Simhadri, Venkateswara R., et al.
Publicado: (2015)

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
por: Lee, Wen Shi, et al.
Publicado: (2015)

Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy
por: Oppenheim, D E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n7m08cnnf6fm09d0enc4kmnvu1